J
Journey Medical Corporation (DERM)
NCM – Real Time Price. Currency in USD
6.62
+0.40 (6.43%)
At close: Jun 26, 2026, 4:00 PM EDT
6.41
-0.21 (-3.17%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
6.62
+0.40 (6.43%)
At close: Jun 26, 2026, 4:00 PM EDT
6.41
-0.21 (-3.17%)
After-hours: Jun 26, 2026, 7:37 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $27.2M significantly exceed its total debt $25.5M, ensuring strong financial flexibility
Total current assets $65.0M exceed Total current liabilities $37.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-1.7x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $2.9M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.72 | 2.52 | 8.0 | |
| Quick ratio | 1.47 | 1.78 | 7.0 | |
| Debt to Equity | 0.83 | -0.80 | 6.0 | |
| Debt to Assets | 0.28 | 0.73 | 7.0 | |
| Interest coverage | -1.67 | -13.90 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 74M | 79M | 56M | 62M | 65M |
| Gross Profit | 43M | 53M | 32M | 37M | 38M |
| Operating Income | -28M | 1M | -18M | -8M | -6M |
| Net Income | -30M | -4M | -15M | -11M | -10M |
| EBITDA | -23M | 5M | -15M | -4M | -2M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 22.37 | 85.94 | 10 |
| Next quarter | 27.02 | 158.33 | 10 |
| Current year | 33.57 | 113.83 | 10 |
| Next year | 66.7 | 1496.15 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -0.72 | -78.82 | -99.99 | 145.75 | 3.3 |
| Y/Y | 21.48 | 45.25 | 55.56 | 202.72 | 10 |
| 3y average | -3.8 | -57.22 | -40.18 | -57.51 | 1.0 |
| 5y average | 9.41 | -214.35 | -14.91 | -57.51 | 2.3 |
| Weighted average score | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |